linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company News  
Piramal Pharma Ltd.
 
BSE Code 543635
ISIN Demat INE0DK501011
Book Value 61.18
NSE Code PPLPHARMA
Dividend Yield % 0.00
Market Cap 228126.50
P/E 32.59
EPS 5.26
Face Value 10  
03-Jun-2026 Piramal Pharma informs about updates
18-May-2026 Piramal Pharma gets EIR from USFDA for Telangana ...
11-May-2026 USFDA concludes GMP inspection at Piramal Pharma’...
29-Apr-2026 Piramal Pharma posts Rs 8.82 crore consolidated n...
29-Apr-2026 Piramal Pharma declines after posting Rs 8.82 cro...
28-Apr-2026 Appointment of Director
28-Apr-2026 Change of Registered Office
13-Apr-2026 Piramal Pharma gets EIR with VAI for USA manufact...
13-Apr-2026 Piramal Pharma informs about updates
13-Apr-2026 Piramal Pharma rises on getting EIR with VAI for ...
01-Apr-2026 Piramal Pharma’s arm completes acquisition of ‘Ke...
21-Mar-2026 Piramal Pharma informs about ESG ratings
16-Feb-2026 USFDA concludes GMP inspection at Piramal Pharma’...
06-Feb-2026 Piramal Pharma’s arm, Blue-Zone collaborate to re...
29-Jan-2026 Piramal Pharma reports consolidated net loss of R...
Page 1 of 2
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.